Santa Rosa, CA7 Active Studies

Advanced Solid Tumors Clinical Trials in Santa Rosa, CA

Find 7 actively recruiting advanced solid tumors clinical trials in Santa Rosa, CA. Connect with local research sites and explore new treatment options.

7
Active Trials
5
Sponsors
3,639
Enrolling

Recruiting Advanced Solid Tumors Studies in Santa Rosa

About Advanced Solid Tumors Clinical Trials in Santa Rosa

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 7 advanced solid tumors clinical trials recruiting participants in Santa Rosa, CA. These studies are seeking a combined 3,639 participants. Research is being sponsored by Genmab, GlaxoSmithKline, Turning Point Therapeutics, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Santa Rosa — FAQ

Are there advanced solid tumors clinical trials in Santa Rosa?

Yes, there are 7 advanced solid tumors clinical trials currently recruiting in Santa Rosa, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Rosa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Rosa research site will contact you about next steps.

Are clinical trials in Santa Rosa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Rosa studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 7 active trials in Santa Rosa are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated July 22, 2026 from ClinicalTrials.gov